Combined Oral Contraceptives: Side Effects Review

Main Article Content

Madina B. Tursinbaeva


The use of contraception prevents an unwanted pregnancy, and also reduces the risk of developing diseases associated with premature pregnancy for women, especially for teenage girls.

The main criteria for choosing a hormonal contraceptive are its effectiveness and safety. Correct assessment of risk factors, indications and contraindications will allow the use of hormonal contraceptives with maximum effect.

For most women, oral contraception is safe, convenient and effective, but you should consult about the possible side effects and the importance of strict adherence to the regimen of oral contraceptives. This review discusses the side effects of combined contraceptives.

Combined oral contraceptives, depression, cancer, obesity, thromboembolism

Article Details

How to Cite
Tursinbaeva, M. B. (2020). Combined Oral Contraceptives: Side Effects Review. Asian Research Journal of Gynaecology and Obstetrics, 4(1), 26-33. Retrieved from
Minireview Article


Family planning/Contraception [Internet].; 2020.


MacGregor A. Efficacy and side-effects of oral contraceptives. Prescriber. 2017; 28(8):19-26.

Grimes D, Schulz K. Nonspecific side effects of oral contraceptives: Nocebo or noise?. Contraception. 2011;83(1):5-9.

Hee L, Kettner L, Vejtorp M. Continuous use of oral contraceptives: An overview of effects and side-effects. Acta Obstetricia et Gynecologica Scandinavica. 2012;92(2): 125-136.

Elevated risk of venous thrombosis with low-dose oral contraceptives. Inpharma Weekly. 2001;1289:21.

Combination estrogen–progestin oral contraceptives. New England Journal of Medicine. 2004;350(1):92-92.

Goldin C, Katz L. The Power of the Pill: Oral contraceptives and women’s career and marriage decisions. Journal of Political Economy. 2002;110(4):730-770.

Selected practice recommendations for contraceptive use (eBook, 2016) [] [Internet].; 2020


Serfaty D. Medical aspects of oral contraceptive discontinuation. Advances in Contraception. 1992;8(S1):21-33.

Ejlsmark- Svensson H, Bislev L, Rolighed L, Sikjaer T, Rejnmark L. Predictors of renal function and calcifications in primary hyperparathyroidism: A nested case-control study. The Journal of Clinical Endocrinology & Metabolism. 2018;103(9): 3574-3583.

Rang HP, Dale MM, Ritter JM, Flower RJ, Henderson G. The reproductive system. Rang and Dale's pharmacology (7th ed.). Edinburgh: Elsevier/Churchill Livingstone. 2012;426.

Eichinger S, Evers J, Glasier A, La Vecchia C, Martinelli I, Skouby S, et al. Venous thromboembolism in women: A specific reproductive health risk. Human Reproduction Update. 2013;19(5):471-482.

Dunn N. The risk of deep venous thrombosis with oral contraceptives containing drospirenone. BMJ. 2011; 342(apr21 2):d2519-d2519.

[Internet]. 2020 [cited 1 July 2020].


La Corte A, Carter A, Turner A, Grant P, Hooper N. The bradykinin-degrading aminopeptidase P is increased in women taking the oral contraceptive pill. Journal of the Renin-Angiotensin-Aldosterone System. 2008;9(4):221-225.

Cibula D, Gompel A, Mueck A, La Vecchia C, Hannaford P, Skouby S, et al. Hormonal contraception and risk of cancer. Human Reproduction Update. 2010;16(6):631-650.

Marchbanks P, McDonald J, Wilson H, Folger S, Mandel M, Daling J, et al. Oral contraceptives and the risk of breast cancer. New England Journal of Medicine. 2002;346(26):2025-2032.

Narod S, Risch H, Moslehi R, Dørum A, Neuhausen S, Olsson H, et al. Oral contraceptives and the risk of hereditary ovarian cancer. New England Journal of Medicine. 1998;339(7):424-428.

Brunner Huber L, Toth J. Obesity and Oral Contraceptive Failure: Findings from the 2002 national survey of family growth. American Journal of Epidemiology. 2007; 166(11):1306-1311.

Huber J, Bentz E, Ott J, Tempfer C. Non-contraceptive benefits of oral contraceptives. Expert Opinion on Pharmacotherapy. 2008;9(13):2317-2325.

Bast R, Brewer M, Zou C, Hernandez M, Daley M, Ozols R, et al. Prevention and early detection of ovarian cancer: Mission impossible? Cancer Prevention. 2007; 91-100.

Speroff L, Darney PD. Oral Contraception. A Clinical Guide for Contraception (4th ed.). Philadelphia: Lippincott Williams & Wilkins. 2005;21–138.

ISBN: 978-0-7817-6488-9.

Speerhas R. Drug metabolism in malnutrition and obesity: Clinical concerns. Cleveland Clinic Journal of Medicine. 1995;62(1):73-75.

Fishman J, Boyar R, Hellman L. Influence of body weight on estradiol metabolism in young women. Obstetrical & Gynecological Survey. 1976;31(4):301-303.

Edelman A, Carlson N, Cherala G, Munar M, Stouffer R, Cameron J, et al. Impact of obesity on oral contraceptive pharmacokinetics and hypothalamic–pituitary–ovarian activity. Contraception. 2009;80(2):119-127.

Hannaford P, Selvaraj S, Elliott A, Angus V, Iversen L, Lee A. Cancer risk among users of oral contraceptives: Cohort data from the Royal College of General Practitioner's oral contraception study. BMJ. 2007;335(7621):651.

Lopez L, Edelman A, Chen M, Otterness C, Trussell J, Helmerhorst F. Progestin-only contraceptives: Effects on weight. Cochrane Database of Systematic Reviews; 2013.

Zethraeus N, Dreber A, Ranehill E, Blomberg L, Labrie F, von Schoultz B et al. Combined oral contraceptives and sexual function in women—a double-blind, randomized, placebo-controlled trial. The Journal of Clinical Endocrinology & Metabolism. 2016;101(11):4046-4053.

Hatcher RD, Nelson AL. Combined Hormonal Contraceptive Methods. In hatcher RD (ed.). Contraceptive technology (18th ed.). New York: Ardent Media, Inc. 2004;403,432,434.

ISBN: 978-0-9664902-5-1.

Seal B, Brotto L, Gorzalka B. Oral contraceptive use and female genital arousal: Methodological considerations. Journal of Sex Research. 2005;42(3):249-258.

Kulkarni J. Depression as a side effect of the contraceptive pill. Expert Opinion on Drug Safety. 2007;6(4):371-374.

Zettermark S, Perez Vicente R, Merlo J. Hormonal contraception increases the risk of psychotropic drug use in adolescent girls but not in adults: A pharmacoepidemiological study on 800 000 Swedish women. PLOS ONE. 2018; 13(3):e0194773.

de Wit A, Booij S, Giltay E, Joffe H, Schoevers R, Oldehinkel A. Association of use of oral contraceptives with depressive symptoms among adolescents and young women. JAMA Psychiatry. 2020;77(1):52.

Skovlund C, Mørch L, Kessing L, Lidegaard Ø. Association of hormonal contraception with depression. JAMA Psychiatry. 2016;73(11):1154.

Young E, Kornstein S, Harvey A, Wisniewski S, Barkin J, Fava M, et al. Influences of hormone-based contraception on depressive symptoms in premenopausal women with major depression. Psychoneuroendocrinology. 2007;32(7):843-853.